Akademisyen
EMEL GÜRKAN
PROFESÖR
ÇUKUROVA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 59
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
14
Q2
15
Q3
18
Q4
7
WoS (JCR)
Q1
5
Q2
11
Q3
18
Q4
24
TR Index
19
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
48.5%
Üst %1 payı
0.0%
Üst %10 payı
1.9%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review YÖKSİS SJR Q2 JCR Q2 OpenAlex 42.8%
- 2025 EZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.3%
- 2025 Venotoclax associated hypothyroidism in a patient with acute myeloid leukemia YÖKSİS SJR Q3 JCR Q4 OpenAlex 81.8%
- 2025 Analysis of killer cell immunoglobulin-like receptor genotypes in acute and chronic myeloid leukemia YÖKSİS TR Index JCR Q4 OpenAlex 10.1%
- 2025 Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia YÖKSİS TR Index OpenAlex 10.0%
- 2025 Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic ThrombocytopenicPurpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 12.0%
- 2024 Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey YÖKSİS SJR Q1 JCR Q1
- 2024 Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program YÖKSİS SJR Q1 JCR Q1
- 2023 Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia YÖKSİS SJR Q3 JCR Q4 OpenAlex 74.0%
- 2023 Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.4%
- 2021 Podocyte Injury in Cases with Newly Diagnosed Multiple Myeloma YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.2%
- 2021 IPS-3 Validation in 1012 cases with classical hodgkin lymphoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 41.5%
- 2021 INCREASED CIRCULATING COPEPTIN LEVELS ARE ASSOCIATED WITH VASO-OCCLUSIVE CRISIS AND RIGHT VENTRICULAR DYSFUNCTION IN SICKLE CELL ANEMIA YÖKSİS SJR Q3 JCR Q3 OpenAlex 60.3%
- 2021 HbA1c level decreases in iron deficiency anemia YÖKSİS SJR Q3 JCR Q3 OpenAlex 85.6%
- 2020 Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma YÖKSİS SJR Q2 JCR Q3 OpenAlex 81.5%
- 2019 Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study YÖKSİS SJR Q1 JCR Q2 OpenAlex 1.9%
- 2019 Zoledronik asit osteoporozlu β-talasemi hastalarında kemik mineral yoğunluğunu arttırır: Bir vaka kontrol çalışması YÖKSİS TR Index JCR Q3 OpenAlex 8.6%
- 2018 Relationship between MTHFR gene polymorphisms (C677T and A1298C) and chronic lymphocytic leukemia in the Turkish population YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.0%
- 2017 Prevalence of cytogenetic abnormalities in chroniclymphocytic leukemia in the southern part of Turkey YÖKSİS SJR Q3 JCR Q4 OpenAlex 25.9%
- 2016 The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 66.9%